Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Best Growth Stocks to Buy for March 3rd
Best Growth Stocks to Buy for March 3rd

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today March 3rd:

HubSpot HUBS: This company, which provides inbound marketing and sales application

Taser 2.0? Sandisk Builds Back-to-Back High Tight Flags
Taser 2.0? Sandisk Builds Back-to-Back High Tight Flags

How Taser Shocked Wall Street in the Early 2000s

In 2002, “stun gun” maker Taser, now called Axon Enterprise (AXON), went on one of the most stunning runs in Wall Street history. From late October

Cameco Inks $1.9B Long-Term Uranium Supply Deal With IndiaPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Cameco Inks $1.9B Long-Term Uranium Supply Deal With India

Cameco Corporation CCJ has strengthened its long-term growth visibility with a fresh supply agreement with India’s Department of Atomic Energy, underscoring its role as a key player in the global

Can Serve Robotics Convert 3,600 Restaurants Into Profitable Density?Photo, wide shot, wide-angle lens,  Grocery store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/9a6c3fc6-53ff-4c6e-848b-263660ac3eb0.png
Can Serve Robotics Convert 3,600 Restaurants Into Profitable Density?

Serve Robotics Inc. SERV is rapidly expanding its commercial footprint, but the real test lies in turning scale into sustainable profitability. With more than 3,600 restaurant locations in the

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a collaboration with DNAstack to launch the world’s first global federated dataset of HiFi whole genome sequencing

NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision

ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator

Can OZK Sustain Returns With Strong Capital Base in Place?Photo, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
Can OZK Sustain Returns With Strong Capital Base in Place?

Bank OZK OZK appears well-positioned to sustain and potentially expand its capital return strategy. The bank has consistently rewarded shareholders through uninterrupted dividend increases over the

Opendoor EBITDA Loss Narrows in 2025: Inflection Point Near?
Opendoor EBITDA Loss Narrows in 2025: Inflection Point Near?

Opendoor Technologies Inc.'s OPEN 2025 results suggest the early stages of an operating inflection, even as headline numbers remain pressured.In fourth-quarter 2025, Opendoor reported an adjusted

Best Value Stocks to Buy for March 3rdPhoto, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
Best Value Stocks to Buy for March 3rd

Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 3rd:  

Blackbaud BLKB: This leading cloud software company which offers a full spectrum of

Halliburton's Asset Sale Halt Paves Way for Venezuela Restart
Halliburton's Asset Sale Halt Paves Way for Venezuela Restart

Halliburton Company’s HAL auction of equipment has been called off by Venezuela after intervention from the U.S. administration. The decision comes as Washington works to facilitate the return of

Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead?
Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead?

Merck MRK has a strong foothold in the oncology market, primarily supported by its biggest revenue driver, Keytruda. The blockbuster PD-1 inhibitor accounts for around 55% of the company’s

DICK'S Sporting's Digital Strategy & Other Efforts Bolster GrowthPhoto, wide shot, wide-angle lens,  Fashion store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/4103ce22-87d6-4bef-ba44-0baf5ab280bb.png
DICK'S Sporting's Digital Strategy & Other Efforts Bolster Growth

DICK'S Sporting Goods, Inc.’s DKS digital strategy is a key growth catalyst, underscoring its rapid evolution into a leading omnichannel sports retailer. Its expanding digital capabilities are

Earnings Preview: Kohl's (KSS) Q4 Earnings Expected to Decline
Earnings Preview: Kohl's (KSS) Q4 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on lower revenues when Kohl's (KSS) reports results for the quarter ended January 2026. While this widely-known consensus outlook is

Zacks Initiates Coverage of Good Times Restaurants With Neutral Recommendation
Zacks Initiates Coverage of Good Times Restaurants With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Good Times Restaurants Inc. GTIM, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Sanofi SNY announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to Waylirz (rilzabrutinib) for the treatment of IgG4-related disease (IgG4-RD)

Arthur J. Gallagher Banks on Solid Segmental Growth Amid Cost Woes
Arthur J. Gallagher Banks on Solid Segmental Growth Amid Cost Woes

Arthur J. Gallagher & Co. AJG continues to benefit from solid retention, improving renewal premiums and organic and inorganic growth.AJG remains focused on generating both organic (particularly

Best Momentum Stock to Buy for March 3rdBild von Steve Bidmead auf Pixabay : https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Best Momentum Stock to Buy for March 3rd

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd:

Sibanye Gold Limited SBSW: This precious metal mining company, with a diverse

3 Reasons Why Mining ETFs Are Shining BrightPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
3 Reasons Why Mining ETFs Are Shining Bright

Metal and mining stocks are shining bright this year, withState Street SPDR S&P Metals & Mining ETF XME gaining 11% so far this year (as of Feb. 27, 2026), clearly outperforming State Street SPDR

Target Beats Q4 Earnings Estimates, Eyes Sales Growth in FY2026
Target Beats Q4 Earnings Estimates, Eyes Sales Growth in FY2026

Target Corporation TGT reported fourth-quarter fiscal 2025 results, wherein the top line fell short of the Zacks Consensus Estimate, while the bottom line surpassed the same. The company continued

Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade

Prothena (PRTA) closed the last trading session at $9.4, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's  What You Should Know
Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's What You Should Know

Senseonics Holdings (SENS) closed the last trading session at $8.33, gaining 14.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Believe Trimble (TRMB) Could Rally 33.68%: Here's is How to Trade
Wall Street Analysts Believe Trimble (TRMB) Could Rally 33.68%: Here's is How to Trade

Shares of Trimble Navigation (TRMB) have gained 0.8% over the past four weeks to close the last trading session at $68.41, but there could still be a solid upside left in the stock if short-term

Does Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?
Does Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?

Shares of Replimune Group, Inc. (REPL) have gained 2.7% over the past four weeks to close the last trading session at $7.16, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts See a 28.36% Upside in On Holding (ONON): Can the Stock Really Move This High?
Wall Street Analysts See a 28.36% Upside in On Holding (ONON): Can the Stock Really Move This High?

Shares of On Holding (ONON) have gained 1.8% over the past four weeks to close the last trading session at $46.76, but there could still be a solid upside left in the stock if short-term price

Should You Buy Central Garden (CENT) After Golden Cross?
Should You Buy Central Garden (CENT) After Golden Cross?

From a technical perspective, Central Garden & Pet Company (CENT) is looking like an interesting pick, as it just reached a key level of support. CENT's 50-day simple moving average crossed above